Relation deepens GSK alliance with $110M deal August 31, 2026 Categories: Health Care Tags: Relation Therapeutics
Relation Therapeutics forms $1.7 billion multi-program collaboration with Novartis advancing therapeutics for atopic diseases December 15, 2025 Categories: Health Care Tags: Relation Therapeutics
Relation announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and osteoarthritis December 16, 2024 Categories: Health Care Tags: Relation Therapeutics
Relation Therapeutics secures $35 million of new seed financing led by DCVC and co-lead NVentures, NVIDIA’s venture arm March 17, 2024 Categories: Health Care Tags: Relation Therapeutics
Relation Therapeutics opens flagship lab in London March 6, 2023 Categories: Health Care Tags: Relation Therapeutics
Relation Therapeutics, the active-graph machine learning drug discovery company, names David Roblin as CEO and Lindsay Edwards as CTO June 10, 2022 Categories: Health Care Tags: Relation Therapeutics
